Treace Medical Concepts
TMCI
135 hedge funds and large institutions have $278M invested in Treace Medical Concepts in 2024 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 42 increasing their positions, 46 reducing their positions, and 22 closing their positions.
736% more call options, than puts
Call options by funds: $1.21M | Put options by funds: $145K
2% more funds holding
Funds holding: 133 → 135 (+2)
9% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 46
9% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 22
3.82% less ownership
Funds ownership: 63.7% → 59.88% (-3.8%)
37% less capital inflows, than outflows
Capital inflows: $24.3M | Capital outflows: $38.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$5.97M |
| 2 |
JP Morgan Chase
New York
|
+$4.78M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
+$3.66M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.28M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$7.58M |
| 2 |
Soleus Capital Management
Greenwich,
Connecticut
|
-$5.15M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5.14M |
| 4 |
BlackRock
New York
|
-$2.73M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$2.26M |
TMCI Hedge Fund Activity: Q4 2024 in Review
135 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q4 2024, worth a combined $278M — up 21% from $230M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of TMCI and 20 opened new positions — a net loss of 2 holders — while 46 trimmed existing stakes and 42 added.
The largest buyer was UBS Group, adding an estimated $5.97M. The largest seller was Morgan Stanley, cutting an estimated $7.58M.
- 135 institutional investors held Treace Medical Concepts (TMCI) as of Q4 2024, up from 133 in Q3 2024.
- Funds reported $278M of Treace Medical Concepts stock for Q4 2024, up 21% quarter-over-quarter.
- 20 funds opened new Treace Medical Concepts positions in Q4 2024 and 22 closed out, a net change of -2 holders.
- The largest Treace Medical Concepts buyer in Q4 2024 was UBS Group, an estimated $5.97M added.
- The largest Treace Medical Concepts seller in Q4 2024 was Morgan Stanley, an estimated $7.58M sold.
Based on aggregated 13F filings for Q4 2024.